4/20
12:18 pm
txg
10x Genomics (TXG) had its price target raised by Canaccord Genuity Group Inc. from $22.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
10x Genomics (TXG) had its price target raised by Canaccord Genuity Group Inc. from $22.00 to $32.00. They now have a "buy" rating on the stock.
4/20
11:45 am
txg
10x Genomics (TXG) had its price target raised by Bank of America Corporation from $21.00 to $30.00. They now have a "neutral" rating on the stock.
Medium
Report
10x Genomics (TXG) had its price target raised by Bank of America Corporation from $21.00 to $30.00. They now have a "neutral" rating on the stock.
4/18
11:35 pm
txg
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [Yahoo! Finance]
Medium
Report
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [Yahoo! Finance]
4/18
10:23 pm
txg
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [TheStreet.com]
Medium
Report
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [TheStreet.com]
4/18
10:00 pm
txg
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
Medium
Report
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
4/15
04:15 pm
txg
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]
Low
Report
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]
4/15
04:05 pm
txg
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
Low
Report
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
4/14
07:13 am
txg
10x Genomics (TXG) had its "overweight" rating reaffirmed by Barclays PLC.
Medium
Report
10x Genomics (TXG) had its "overweight" rating reaffirmed by Barclays PLC.
4/7
02:33 pm
txg
10x Genomics (TXG) had its price target raised by Citigroup Inc. from $18.00 to $24.00. They now have a "neutral" rating on the stock.
Low
Report
10x Genomics (TXG) had its price target raised by Citigroup Inc. from $18.00 to $24.00. They now have a "neutral" rating on the stock.
3/31
08:41 am
txg
10x Genomics (TXG) was upgraded by William Blair from "market perform" to "outperform".
Low
Report
10x Genomics (TXG) was upgraded by William Blair from "market perform" to "outperform".
3/25
07:00 am
txg
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Low
Report
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
3/25
07:00 am
txg
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Low
Report
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
3/25
07:00 am
txg
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Low
Report
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
3/17
08:12 am
txg
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas [Yahoo! Finance]
Medium
Report
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas [Yahoo! Finance]
3/17
08:00 am
txg
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
Medium
Report
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
3/6
05:58 pm
txg
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers [Yahoo! Finance]
Low
Report
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers [Yahoo! Finance]
3/2
09:04 am
txg
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
2/20
07:04 am
txg
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/19
04:05 pm
txg
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
Low
Report
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
2/13
10:16 am
txg
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at TD Cowen.
Medium
Report
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at TD Cowen.
2/13
10:14 am
txg
10x Genomics (NASDAQ:TXG) was given a new $17.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.
Medium
Report
10x Genomics (NASDAQ:TXG) was given a new $17.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.
2/13
09:09 am
txg
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Stifel Nicolaus.
Low
Report
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Stifel Nicolaus.
2/13
09:09 am
txg
10x Genomics (NASDAQ:TXG) was given a new $22.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
10x Genomics (NASDAQ:TXG) was given a new $22.00 price target on by analysts at Canaccord Genuity Group Inc..
2/13
12:35 am
txg
10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amid ... [Yahoo! Finance]
Low
Report
10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amid ... [Yahoo! Finance]
2/12
05:11 pm
txg
10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 [Yahoo! Finance]
Low
Report
10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 [Yahoo! Finance]